PMC:7068984 / 12162-14020
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
422 | 34-39 | Gene | denotes | Spike | Gene:43740568 |
423 | 61-65 | Gene | denotes | ACE2 | Gene:59272 |
424 | 273-277 | Gene | denotes | ACE2 | Gene:59272 |
425 | 293-315 | Gene | denotes | Dipeptidyl peptidase-4 | Gene:1803 |
426 | 317-321 | Gene | denotes | DPP4 | Gene:1803 |
427 | 326-329 | Gene | denotes | APN | Gene:290 |
428 | 331-347 | Gene | denotes | Aminopeptidase N | Gene:290 |
429 | 437-441 | Gene | denotes | ACE2 | Gene:59272 |
430 | 692-723 | Gene | denotes | transmembrane protease serine 2 | Gene:7113 |
431 | 725-732 | Gene | denotes | TMPRSS2 | Gene:7113 |
432 | 41-42 | Gene | denotes | S | Gene:43740568 |
433 | 559-564 | Gene | denotes | Spike | Gene:43740568 |
434 | 23-33 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
435 | 222-227 | Species | denotes | β-CoV | Tax:694002 |
436 | 250-255 | Species | denotes | human | Tax:9606 |
437 | 287-292 | Species | denotes | human | Tax:9606 |
438 | 373-383 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
439 | 500-508 | Species | denotes | SARS-CoV | Tax:694009 |
440 | 548-558 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
441 | 605-613 | Species | denotes | SARS-CoV | Tax:694009 |
442 | 826-836 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
443 | 939-949 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
444 | 997-1002 | Species | denotes | human | Tax:9606 |
445 | 1025-1030 | Species | denotes | human | Tax:9606 |
446 | 1031-1039 | Species | denotes | SARS-CoV | Tax:694009 |
447 | 1096-1102 | Species | denotes | people | Tax:9606 |
448 | 1519-1529 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
449 | 1560-1568 | Species | denotes | SARS-CoV | Tax:694009 |
450 | 1573-1581 | Species | denotes | MERS-CoV | Tax:1335626 |
451 | 1756-1761 | Species | denotes | human | Tax:9606 |
452 | 1765-1770 | Species | denotes | human | Tax:9606 |
453 | 1817-1827 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
454 | 1003-1012 | Disease | denotes | infection | MESH:D007239 |
455 | 1087-1095 | Disease | denotes | infected | MESH:D007239 |
456 | 1227-1236 | Disease | denotes | pneumonia | MESH:D011014 |
457 | 1611-1620 | Disease | denotes | mortality | MESH:D003643 |
458 | 1624-1632 | Disease | denotes | COVID-19 | MESH:C000657245 |
459 | 1653-1658 | Disease | denotes | death | MESH:D003643 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T72 | 44-56 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T73 | 256-261 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T74 | 425-432 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T75 | 640-647 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T76 | 668-680 | Body_part | denotes | cell surface | http://purl.org/sig/ont/fma/fma67653 |
T77 | 668-672 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T78 | 715-721 | Body_part | denotes | serine | http://purl.org/sig/ont/fma/fma82764 |
LitCovid_AGAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p13914s6 | 423-432 | Protein | denotes | S-protein |
p13914s10 | 437-441 | Protein | denotes | ACE2 |
p13914s11 | 442-449 | Interaction | denotes | binding |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T89 | 23-31 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T90 | 373-381 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T91 | 500-508 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T92 | 548-556 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T93 | 605-613 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T94 | 826-834 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T95 | 939-947 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T96 | 1003-1012 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T97 | 1031-1039 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T98 | 1227-1236 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T99 | 1519-1527 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T100 | 1560-1568 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T101 | 1624-1632 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T102 | 1667-1671 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T103 | 1817-1825 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T112 | 78-79 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T113 | 98-103 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T114 | 111-116 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T115 | 250-261 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cells |
T116 | 287-292 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T117 | 668-672 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T118 | 800-808 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T119 | 997-1002 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T120 | 1025-1030 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T121 | 1696-1698 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T122 | 1756-1761 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T123 | 1765-1770 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T44 | 44-56 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T45 | 425-432 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T46 | 528-530 | Chemical | denotes | EM | http://purl.obolibrary.org/obo/CHEBI_73507 |
T47 | 640-647 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T48 | 715-721 | Chemical | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
T49 | 778-787 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T18 | 800-821 | http://purl.obolibrary.org/obo/GO_0010324 | denotes | membrane invagination |
T19 | 837-848 | http://purl.obolibrary.org/obo/GO_0006897 | denotes | endocytosis |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T86 | 0-197 | Sentence | denotes | Because the binding of SARS-CoV-2 Spike (S) glycoprotein and ACE2 receptor is a critical step for virus entry, virus-receptor binding affinity is under intensive study through different approaches. |
T87 | 198-389 | Sentence | denotes | Systematic detection of β-CoV receptors showed that human cells expressing ACE2, but not human Dipeptidyl peptidase-4 (DPP4) or APN (Aminopeptidase N), were enhanced entry of SARS-CoV-2 [37]. |
T88 | 390-600 | Sentence | denotes | While, another study showed that S-protein and ACE2 binding efficiency is 10- to 20- fold higher than that of SARS-CoV, evidenced by Cryo-EM Structure of the SARS-CoV-2 Spike in the prefusion conformation [38]. |
T89 | 601-867 | Sentence | denotes | For SARS-CoV, the cleavage of trimer S protein is triggered by the cell surface-associated transmembrane protease serine 2 (TMPRSS2) [39] and cathepsin [40], while the possible molecules facilitated membrane invagination for SARS-CoV-2 endocytosis are still unclear. |
T90 | 868-1040 | Sentence | denotes | Up to the date this review paper was prepared, reports showed that the SARS-CoV-2 may readily transmit, while cause less serious human infection rather than human SARS-CoV. |
T91 | 1041-1151 | Sentence | denotes | Based on the latest WHO report, the number of infected people (over 80,000 globally, updated on 1 March 2020). |
T92 | 1152-1317 | Sentence | denotes | The global outbreak may due to the following factors: firstly, the unknown pneumonia outbroke at the time of China Spring Festival, when the mass population flowing. |
T93 | 1318-1475 | Sentence | denotes | Secondly, more detailed molecular mechanisms of viral binding and entry manners await to be elucidated, which may hamper the development of targeted therapy. |
T94 | 1476-1720 | Sentence | denotes | Thirdly, available data suggested that the SARS-CoV-2 may be less virulent than the SARS-CoV and MERS-CoV, with the currently analyzed mortality of COVID-19 is 3.4%, lower than death rate of SARS (9.6%) and MERS (around 35%), respectively [19]. |
T95 | 1721-1858 | Sentence | denotes | Thus, the potential mechanisms for human-to-human transmission and pathogenic mechanisms of the SARS-CoV-2 are under extensively studied. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T14 | 1227-1236 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32169119-30102747-70132211 | 596-598 | 30102747 | denotes | 38 |
32169119-25445340-70132212 | 735-737 | 25445340 | denotes | 39 |
32169119-27344959-70132213 | 1716-1718 | 27344959 | denotes | 19 |